[The proliferative response of T cells against cruzipain in chronic chagasic cardiopathy]

Area of Science:

• Immunology
• Cardiology
• Infectious Diseases

Background:

• Chagas disease, caused by Trypanosoma cruzi, can lead to chronic cardiomyopathy.
• Distinguishing chagasic cardiomyopathy from non-chagasic forms is clinically important.
• Cruzipain (GP57/51) is a major antigen of Trypanosoma cruzi.

Purpose of the Study:

• To determine if T cell proliferative responses to cruzipain can differentiate chronic chagasic cardiomyopathy from non-chagasic cardiomyopathy.
• To investigate the role of T cell responses to cruzipain in the pathogenesis of Chagas disease.

Main Methods:

• Peripheral blood mononuclear cells were isolated from normal donors, patients with non-chagasic cardiomyopathy, and patients with chronic chagasic cardiomyopathy.
• T cell proliferative responses to cruzipain were measured using proliferation assays.
• Statistical analysis (ANOVA, Turkey's multiple comparison test) was performed to compare responses between groups.

Main Results:

• T cell proliferative responses to cruzipain were significantly higher in patients with chronic chagasic cardiomyopathy compared to normal donors and patients with non-chagasic cardiomyopathy (p = 0.0001).
• No significant difference in proliferative responses to cruzipain was observed between normal donors and patients with non-chagasic cardiomyopathy.
• T cell responses to cruzipain are exclusively associated with Chagas disease.

Conclusions:

• T cell proliferative responses to cruzipain serve as a specific biomarker for Chagas disease.
• These T cell responses may contribute to the cardiac tissue damage observed in chronic Chagasic patients.
• Targeting cruzipain-specific T cells could be a potential therapeutic strategy for Chagas disease.